Ningbo David Medical Device Co., Ltd. (SHE:300314)
China flag China · Delayed Price · Currency is CNY
14.19
+0.23 (1.65%)
Mar 10, 2026, 10:45 AM CST

SHE:300314 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
4,0203,2434,3603,7383,9174,732
Market Cap Growth
21.08%-25.63%16.64%-4.56%-17.22%75.72%
Enterprise Value
3,4322,6303,6113,0723,3164,167
Last Close Price
13.9611.1814.7912.5813.0415.60
PE Ratio
60.0456.6329.5438.4048.8334.74
Forward PE
-40.8440.8440.8440.8440.84
PS Ratio
7.786.157.057.398.2610.30
PB Ratio
3.302.783.753.533.954.96
P/TBV Ratio
3.432.893.913.704.075.12
P/FCF Ratio
263.81-45.9960.5087.1441.68
P/OCF Ratio
42.4834.5532.2533.5176.0834.36
PEG Ratio
-0.670.670.670.670.67
EV/Sales Ratio
6.644.995.846.076.999.07
EV/EBITDA Ratio
42.6431.6223.3628.2036.9534.59
EV/EBIT Ratio
59.3743.5628.3835.9350.5442.10
EV/FCF Ratio
225.17-38.0949.7173.7836.70
Debt / Equity Ratio
0.010.010.010.010.00-
Debt / EBITDA Ratio
0.090.100.090.130.01-
Debt / FCF Ratio
0.49-0.140.240.01-
Net Debt / Equity Ratio
-0.48-0.57-0.67-0.69-0.69-0.71
Net Debt / EBITDA Ratio
-7.63-8.02-5.03-6.68-7.65-5.60
Net Debt / FCF Ratio
-38.6514.55-8.21-11.77-15.28-5.94
Asset Turnover
0.370.380.470.420.420.44
Inventory Turnover
1.161.371.711.471.531.95
Quick Ratio
2.953.044.154.324.384.16
Current Ratio
4.063.885.035.235.284.84
Return on Equity (ROE)
5.56%4.91%13.28%9.50%8.25%15.28%
Return on Assets (ROA)
2.60%2.71%6.06%4.44%3.60%5.93%
Return on Invested Capital (ROIC)
8.68%12.30%31.51%23.41%20.68%33.77%
Return on Capital Employed (ROCE)
4.70%5.10%10.80%7.90%6.60%10.40%
Earnings Yield
1.66%1.77%3.38%2.60%2.05%2.88%
FCF Yield
0.38%-1.41%2.17%1.65%1.15%2.40%
Dividend Yield
0.61%0.78%1.22%1.19%0.77%0.96%
Payout Ratio
37.64%90.53%29.27%29.58%53.86%8.46%
Buyback Yield / Dilution
1.08%1.08%-1.08%0.04%1.14%-2.73%
Total Shareholder Return
1.69%1.85%0.14%1.23%1.91%-1.76%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.